219 related articles for article (PubMed ID: 31483818)
1. Display of malaria transmission-blocking antigens on chimeric duck hepatitis B virus-derived virus-like particles produced in Hansenula polymorpha.
Wetzel D; Chan JA; Suckow M; Barbian A; Weniger M; Jenzelewski V; Reiling L; Richards JS; Anderson DA; Kouskousis B; Palmer C; Hanssen E; Schembecker G; Merz J; Beeson JG; Piontek M
PLoS One; 2019; 14(9):e0221394. PubMed ID: 31483818
[TBL] [Abstract][Full Text] [Related]
2. Establishment of a yeast-based VLP platform for antigen presentation.
Wetzel D; Rolf T; Suckow M; Kranz A; Barbian A; Chan JA; Leitsch J; Weniger M; Jenzelewski V; Kouskousis B; Palmer C; Beeson JG; Schembecker G; Merz J; Piontek M
Microb Cell Fact; 2018 Feb; 17(1):17. PubMed ID: 29402276
[TBL] [Abstract][Full Text] [Related]
3. Malaria vaccine candidates displayed on novel virus-like particles are immunogenic and induce transmission-blocking activity.
Chan JA; Wetzel D; Reiling L; Miura K; Drew DR; Gilson PR; Anderson DA; Richards JS; Long CA; Suckow M; Jenzelewski V; Tsuboi T; Boyle MJ; Piontek M; Beeson JG
PLoS One; 2019; 14(9):e0221733. PubMed ID: 31504038
[TBL] [Abstract][Full Text] [Related]
4. Bioprocess optimization for purification of chimeric VLP displaying BVDV E2 antigens produced in yeast Hansenula polymorpha.
Wetzel D; Barbian A; Jenzelewski V; Schembecker G; Merz J; Piontek M
J Biotechnol; 2019 Dec; 306():203-212. PubMed ID: 31634510
[TBL] [Abstract][Full Text] [Related]
5. Safety and immunogenicity of a plant-produced Pfs25 virus-like particle as a transmission blocking vaccine against malaria: A Phase 1 dose-escalation study in healthy adults.
Chichester JA; Green BJ; Jones RM; Shoji Y; Miura K; Long CA; Lee CK; Ockenhouse CF; Morin MJ; Streatfield SJ; Yusibov V
Vaccine; 2018 Sep; 36(39):5865-5871. PubMed ID: 30126674
[TBL] [Abstract][Full Text] [Related]
6. A plant-produced Pfs25 VLP malaria vaccine candidate induces persistent transmission blocking antibodies against Plasmodium falciparum in immunized mice.
Jones RM; Chichester JA; Mett V; Jaje J; Tottey S; Manceva S; Casta LJ; Gibbs SK; Musiychuk K; Shamloul M; Norikane J; Mett V; Streatfield SJ; van de Vegte-Bolmer M; Roeffen W; Sauerwein RW; Yusibov V
PLoS One; 2013; 8(11):e79538. PubMed ID: 24260245
[TBL] [Abstract][Full Text] [Related]
7. Novel Virus-Like Particle Vaccine Encoding the Circumsporozoite Protein of
Kurtovic L; Wetzel D; Reiling L; Drew DR; Palmer C; Kouskousis B; Hanssen E; Wines BD; Hogarth PM; Suckow M; Jenzelewski V; Piontek M; Chan JA; Beeson JG
Front Immunol; 2021; 12():641421. PubMed ID: 33815393
[TBL] [Abstract][Full Text] [Related]
8. Improving the malaria transmission-blocking activity of a Plasmodium falciparum 48/45 based vaccine antigen by SpyTag/SpyCatcher mediated virus-like display.
Singh SK; Thrane S; Janitzek CM; Nielsen MA; Theander TG; Theisen M; Salanti A; Sander AF
Vaccine; 2017 Jun; 35(30):3726-3732. PubMed ID: 28578824
[TBL] [Abstract][Full Text] [Related]
9.
Singh SK; Thrane S; Chourasia BK; Teelen K; Graumans W; Stoter R; van Gemert GJ; van de Vegte-Bolmer MG; Nielsen MA; Salanti A; Sander AF; Sauerwein RW; Jore MM; Theisen M
Front Immunol; 2019; 10():1256. PubMed ID: 31231386
[TBL] [Abstract][Full Text] [Related]
10. Heat-precipitation allows the efficient purification of a functional plant-derived malaria transmission-blocking vaccine candidate fusion protein.
Beiss V; Spiegel H; Boes A; Kapelski S; Scheuermayer M; Edgue G; Sack M; Fendel R; Reimann A; Schillberg S; Pradel G; Fischer R
Biotechnol Bioeng; 2015 Jul; 112(7):1297-305. PubMed ID: 25615702
[TBL] [Abstract][Full Text] [Related]
11. Novel adenovirus encoded virus-like particles displaying the placental malaria associated VAR2CSA antigen.
Andersson AC; Resende M; Salanti A; Nielsen MA; Holst PJ
Vaccine; 2017 Feb; 35(8):1140-1147. PubMed ID: 28131394
[TBL] [Abstract][Full Text] [Related]
12. Assessment of Pfs25 expressed from multiple soluble expression platforms for use as transmission-blocking vaccine candidates.
Lee SM; Wu CK; Plieskatt J; McAdams DH; Miura K; Ockenhouse C; King CR
Malar J; 2016 Aug; 15(1):405. PubMed ID: 27515826
[TBL] [Abstract][Full Text] [Related]
13. Identification of domains within Pfs230 that elicit transmission blocking antibody responses.
Tachibana M; Miura K; Takashima E; Morita M; Nagaoka H; Zhou L; Long CA; Richter King C; Torii M; Tsuboi T; Ishino T
Vaccine; 2019 Mar; 37(13):1799-1806. PubMed ID: 30824357
[TBL] [Abstract][Full Text] [Related]
14. Engineering of a plant-produced virus-like particle to improve the display of the Plasmodium falciparum Pfs25 antigen and transmission-blocking activity of the vaccine candidate.
Tottey S; Shoji Y; Mark Jones R; Musiychuk K; Chichester JA; Miura K; Zhou L; Lee SM; Plieskatt J; Wu Y; Long CA; Streatfield SJ; Yusibov V
Vaccine; 2023 Jan; 41(4):938-944. PubMed ID: 36585278
[TBL] [Abstract][Full Text] [Related]
15. A novel plant-produced Pfs25 fusion subunit vaccine induces long-lasting transmission blocking antibody responses.
Jones RM; Chichester JA; Manceva S; Gibbs SK; Musiychuk K; Shamloul M; Norikane J; Streatfield SJ; van de Vegte-Bolmer M; Roeffen W; Sauerwein RW; Yusibov V
Hum Vaccin Immunother; 2015; 11(1):124-32. PubMed ID: 25483525
[TBL] [Abstract][Full Text] [Related]
16. Algae-produced Pfs25 elicits antibodies that inhibit malaria transmission.
Gregory JA; Li F; Tomosada LM; Cox CJ; Topol AB; Vinetz JM; Mayfield S
PLoS One; 2012; 7(5):e37179. PubMed ID: 22615931
[TBL] [Abstract][Full Text] [Related]
17. Enhancing immunogenicity and transmission-blocking activity of malaria vaccines by fusing Pfs25 to IMX313 multimerization technology.
Li Y; Leneghan DB; Miura K; Nikolaeva D; Brian IJ; Dicks MD; Fyfe AJ; Zakutansky SE; de Cassan S; Long CA; Draper SJ; Hill AV; Hill F; Biswas S
Sci Rep; 2016 Jan; 6():18848. PubMed ID: 26743316
[TBL] [Abstract][Full Text] [Related]
18. A Universal Plug-and-Display Vaccine Carrier Based on HBsAg VLP to Maximize Effective Antibody Response.
Marini A; Zhou Y; Li Y; Taylor IJ; Leneghan DB; Jin J; Zaric M; Mekhaiel D; Long CA; Miura K; Biswas S
Front Immunol; 2019; 10():2931. PubMed ID: 31921185
[TBL] [Abstract][Full Text] [Related]
19. Structural and Immunological Characterization of Recombinant 6-Cysteine Domains of the Plasmodium falciparum Sexual Stage Protein Pfs230.
MacDonald NJ; Nguyen V; Shimp R; Reiter K; Herrera R; Burkhardt M; Muratova O; Kumar K; Aebig J; Rausch K; Lambert L; Dawson N; Sattabongkot J; Ambroggio X; Duffy PE; Wu Y; Narum DL
J Biol Chem; 2016 Sep; 291(38):19913-22. PubMed ID: 27432885
[TBL] [Abstract][Full Text] [Related]
20. Global diversity of the gene encoding the Pfs25 protein-a Plasmodium falciparum transmission-blocking vaccine candidate.
Sookpongthai P; Utayopas K; Sitthiyotha T; Pengsakul T; Kaewthamasorn M; Wangkanont K; Harnyuttanakorn P; Chunsrivirot S; Pattaradilokrat S
Parasit Vectors; 2021 Nov; 14(1):571. PubMed ID: 34749796
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
